| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 23.9 K | $360 K | $15.04 | Jun 13, 2024 | Direct |
| X4 Pharmaceuticals, Inc | Director | Common Stock | 135 K | $119 K | $0.88 | Jun 10, 2024 | Direct |
| TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 47.5 K | Jun 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | Jun 13, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| TCRX | TScan Therapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Dec 7, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Director |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Dec 7, 2023 | 0 | $0 | 3 | Dec 12, 2023 | Director |
| TCRX | TScan Therapeutics, Inc. | Dec 6, 2023 | 1 | $0 | 4 | Dec 8, 2023 | Director |
| TCRX | TScan Therapeutics, Inc. | Dec 6, 2023 | 0 | $0 | 3 | Dec 8, 2023 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Oct 16, 2023 | 1 | $0 | 4 | Oct 18, 2023 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Oct 16, 2023 | 0 | $0 | 3 | Oct 18, 2023 | Director |